"increased government scrutiny and regulation" - What!, link? Oh, you mean the Credit Suisse report which "raised the spectre of new regulations around how migrant donors contribute plasma" and the "sector's reliance on donors from low-socioeconomic backgrounds". Now why would be Credit Suisse be doing that?, concern for the health of migrants and the poor? Answer, no, not health anyway:
"Generally, the body is able to regenerate the lost plasma volume within a short amount of time. To give the body some time to recover, the FDA recommends that people limit their donation rate to every 48 hours, or twice a week, and no more than 110 donations per year."
By the way, do you have any links that, to quote you, "CSL to be placed under more scrutiny regarding sourcing it’s blood donations!"?, being in mind that donating blood is not the same as donating plasma.
"new regulations" spruiked by Credit Suisse lol.
- Forums
- ASX - By Stock
- CSL
- The Great Manipulator
The Great Manipulator, page-27
-
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$300.01 |
Change
-0.760(0.25%) |
Mkt cap ! $145.3B |
Open | High | Low | Value | Volume |
$301.69 | $304.00 | $298.71 | $134.3M | 445.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2 | $300.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$300.01 | 64 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 153 | 299.920 |
8 | 52 | 299.900 |
1 | 16 | 299.890 |
3 | 84 | 299.870 |
1 | 20 | 299.860 |
Price($) | Vol. | No. |
---|---|---|
299.950 | 164 | 16 |
299.960 | 52 | 3 |
299.970 | 121 | 7 |
299.980 | 14 | 2 |
299.990 | 51 | 5 |
Last trade - 14.22pm 15/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online